Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Second Affiliated Hospital of Nanchang University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
lung-neoplasmsnanon-small-cell-lung-cancer
leptomeningeal metastasis, lung neoplasms, non-small cell lung cancer, non-small cell lung cancer, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833194
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.